Hydrogen-rich water improves cognitive impairment gender-dependently in APP/PS1 mice without affecting Aβ clearance

References

• Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353–356.
   PubMed Web of Science ®Google Scholar
• Mayeux R, Stern Y. Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(8).
   PubMed Web of Science ®Google Scholar
• Sultana R, Butterfield DA. Role of oxidative stress in the progression of Alzheimer’s disease. JAD. 2010;19(1):341–353.
   Google Scholar
• Wirths O, Breyhan H, Marcello A, et al. Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer’s disease. Neurobiol Aging. 2010;31(5):747–757.
   PubMed Web of Science ®Google Scholar
• Manczak M, Anekonda TS, Henson E, et al. Mitochondria are a direct site of A beta accumulation in Alzheimer’s disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet. 2006;15(9):1437–1449.
   PubMed Web of Science ®Google Scholar
• De Felice FG, Velasco PT, Lambert MP, et al. Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem. 2007;282(15):11590–11601.
   PubMed Web of Science ®Google Scholar
• Jia JP, Meng R, Sun YX, et al. Cerebrospinal fluid tau, A beta(1–42) and inflammatory cytokines in patients with Alzheimer’s disease and vascular dementia. Neurosci Lett. 2005;383(1–2):12–16.
   PubMed Web of Science ®Google Scholar
• Ohsawa I, Ishikawa M, Takahashi K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 2007;13(6):688–694.
   PubMed Web of Science ®Google Scholar
• Kawai D, Takaki A, Nakatsuka A, et al. Hydrogen-rich water prevents progression of nonalcoholic steatohepatitis and accompanying hepatocarcinogenesis in mice. Hepatology. 2012;56(3):912–921.
   PubMed Web of Science ®Google Scholar
• Cui YM, Zhang H, Ji MH, et al. Hydrogen-rich saline attenuates neuronal ischemia – reperfusion injury by protecting mitochondrial function in rats. J Surg Res. 2014;192(2):564–572.
   PubMed Web of Science ®Google Scholar
• Mano Y, Kotani T, Ito M, et al. Maternal molecular hydrogen administration ameliorates rat fetal hippocampal damage caused by in utero ischemia-reperfusion. Free Radic Biol Med. 2014;69:324–330.
   PubMed Web of Science ®Google Scholar
• Li J, Wang C, Zhang JH, et al. Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer’s disease by reduction of oxidative stress. Brain Res. 2010;1328:152–161.
   PubMed Web of Science ®Google Scholar
• Wang C, Li JA, Liu QA, et al. Hydrogen-rich saline reduces oxidative stress and inflammation by inhibit of JNK and NF-kappaB activation in a rat model of amyloid-beta-induced Alzheimer’s disease. Neurosci Lett. 2011;491(2):127–132.
   PubMed Web of Science ®Google Scholar
• Tang Z, Li S, Han P, et al. Pertussis toxin reduces calcium influx to protect ischemic stroke in a middle cerebral artery occlusion model. J Neurochem. 2015;135(5):998–1006.
   PubMed Web of Science ®Google Scholar
• Hou C, Wang Y, Zhu E, et al. Coral calcium hydride prevents hepatic steatosis in high fat diet-induced obese rats: a potent mitochondrial nutrient and phase II enzyme inducer. Biochem Pharmacol. 2016;103:85–97.
   PubMed Web of Science ®Google Scholar
• Puoliväli J, Wang J, Heikkinen T, et al. Hippocampal A beta 42 levels correlate with spatial memory deficit in APP and PS1 double transgenic mice. Neurobiol Dis. 2002;9(3):339–347.
   PubMed Web of Science ®Google Scholar
• Feng ZH, Jia HQ, Li XS, et al. A milk-based wolfberry preparation prevents prenatal stress-induced cognitive impairment of offspring rats, and inhibits oxidative damage and mitochondrial dysfunction in vitro. Neurochem Res. 2010;35(5):702–711.
   PubMed Web of Science ®Google Scholar
• Peng YH, Liu J, Tang Y, et al. High-fat-diet-induced weight gain ameliorates bone loss without exacerbating A beta PP processing and cognition in female APP/PS1 mice. Front Cell Neurosci. 2014;8:255.
   PubMed Web of Science ®Google Scholar
• Tang YP, Haslam SZ, Conrad SE, et al. 2004. Estrogen increases brain expression of the mRNA encoding transthyretin, an amyloid beta scavenger protein. J Alzheimers Dis. 6(4):413–420.
   PubMed Web of Science ®Google Scholar
• Goodenough S, Schleusner D, Pietrzik C, et al. Glycogen synthase kinase 3beta links neuroprotection by 17beta-estradiol to key Alzheimer processes. Neuroscience. 2005;132(3):581–589.
   PubMed Web of Science ®Google Scholar
• Cervellati C, Romani A, Bosi C, et al. Serum levels of hydroperoxides and multimorbidity among older patients with mild cognitive impairment or late-onset Alzheimer’s disease. Aging Clin Exp Res. 2015;27(6):799–804.
   PubMed Web of Science ®Google Scholar
• Shi JQ, Zhang CC, Sun XL, et al. Antimalarial drug artemisinin extenuates amyloidogenesis and neuroinflammation in APPswe/PS1dE9 transgenic mice via inhibition of nuclear factor-kappaB and NLRP3 inflammasome activation. CNS Neurosci Ther. 2013;19(4):262–268.
   PubMed Web of Science ®Google Scholar
• Giannakopoulos P, Herrmann FR, Bussière T, et al. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease. Neurology. 2003;60(9):1495–1500.
   PubMed Web of Science ®Google Scholar
• Atwood CS, Obrenovich ME, Liu TB, et al. Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta. Brain Res Brain Res Rev. 2003;43(1):1–16.
   PubMedGoogle Scholar
• Caccamo A, Maldonado MA, Bokov AF, et al. CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci USA. 2010;107(52):22687–22692.
   PubMed Web of Science ®Google Scholar
• Peng Y, Hou C, Yang Z, et al. Hydroxytyrosol mildly improve cognitive function independent of APP processing in APP/PS1 mice. Mol Nutr Food Res. 2016;60(11):2331–2342.
   PubMed Web of Science ®Google Scholar
• Barnes LL, Wilson RS, Bienias JL, et al. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry. 2005;62(6):685–691.
   PubMedGoogle Scholar
• Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women – the Women’s Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289(20):2651–2662.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick JL, Mize AL, Wade CB, et al. Estrogen-mediated neuroprotection against beta-amyloid toxicity requires expression of estrogen receptor alpha or beta and activation of the MAPK pathway. J Neurochem. 2002;82(3):674–682.
   PubMed Web of Science ®Google Scholar
• Cordey M, Gundimeda U, Gopalakrishna R, et al. Estrogen activates protein kinase C in neurons: role in neuroprotection. J Neurochem. 2003;84(6):1340–1348.
   PubMed Web of Science ®Google Scholar
• Long JG, He P, Shen Y, et al. New evidence of mitochondria dysfunction in the female Alzheimer’s disease brain: deficiency of estrogen receptor-β. J Alzheimers Dis. 2012;30(3):545–558.
   PubMed Web of Science ®Google Scholar
• Nagahara AH, Merrill DA, Coppola G, et al. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer’s disease. Nat Med. 2009;15(3):331–337.
   PubMed Web of Science ®Google Scholar
• Zhao LQ, Mao ZS, Schneider LS, et al. Estrogen receptor beta-selective phytoestrogenic formulation prevents physical and neurological changes in a preclinical model of human menopause. Menopause. 2011;18(10):1131–1142.
   PubMed Web of Science ®Google Scholar
• Aguirre C, Jayaraman A, Pike C, et al. Progesterone inhibits estrogen-mediated neuroprotection against excitotoxicity by down-regulating estrogen receptor-β. J Neurochem. 2010;115(5):1277–1287.
   PubMed Web of Science ®Google Scholar
• Zhang HR, Peng JH, Cheng XB, et al. Paeoniflorin Atttenuates amyloidogenesis and the inflammatory responses in a transgenic mouse model of Alzheimer’s disease. Neurochem Res. 2015;40(8):1583–1592.
   PubMed Web of Science ®Google Scholar
• van de Veerdonk FL, Netea MG, Dinarello CA, et al. Inflammasome activation and IL-1beta and IL-18 processing during infection. Trends Immunol. 2011;32(3):110–116.
   PubMed Web of Science ®Google Scholar
• Heneka MT, Kummer MP, Stutz A, et al. NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature. 2013;493(7434):674–678.
   PubMed Web of Science ®Google Scholar
• Saïd-Sadier N, Padilla E, Langsley G, et al. Aspergillus fumigatus stimulates the NLRP3 inflammasome through a pathway requiring ROS Production and the Syk tyrosine kinase. PLoS ONE. 2010;5(4):e10008.
   PubMedGoogle Scholar
• Kauppinen A, Niskanen H, Suuronen T, et al. Oxidative stress activates NLRP3 inflammasomes in ARPE-19 cells - Implications for age-related macular degeneration (AMD). Immunol Lett. 2012;147(1–2):29–33.
   PubMed Web of Science ®Google Scholar
• Shimada K, Crother TR, Karlin J, et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity. 2012;36(3):401–414.
   PubMed Web of Science ®Google Scholar
• Liu JK, Shen WL, Zhao BL, et al. Targeting mitochondrial biogenesis for preventing and treating insulin resistance in diabetes and obesity: hope from natural mitochondrial nutrients. Adv Drug Deliv Rev. 2009;61(14):1343–1352.
   PubMed Web of Science ®Google Scholar
• Manczak M, Mao PZ, Calkins MJ, et al. Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer’s disease neurons. J Alzheimers Dis. 2010;20:S609–SS631.
   PubMed Web of Science ®Google Scholar
• Morale MC, Serra PA, L’Episcopo F, et al. Estrogen, neuroinflammation and neuroprotection in Parkinson’s disease: glia dictates resistance versus vulnerability to neurodegeneration. Neuroscience. 2006;138(3):869–878.
   PubMed Web of Science ®Google Scholar
• Valles SL, Dolz-Gaiton P, Gambini J, et al. Estradiol or genistein prevent Alzheimer’s disease-associated inflammation correlating with an increase PPAR gamma expression in cultured astrocytes. Brain Res. 2010;1312:138–144.
   PubMed Web of Science ®Google Scholar
• Shea TB, Ortiz D. 17 Beta-estradiol alleviates synergistic oxidative stress resulting from folate deprivation and amyloid-beta treatment. J Alzheimers Dis. 2003;5(4):323–327.
   PubMedGoogle Scholar
• Gezen-Ak D, Dursun E, Hanagasi H, et al. BDNF, TNFalpha, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer’s disease or mild cognitive impairment. J Alzheimers Dis. 2013;37(1):185–195.
   PubMed Web of Science ®Google Scholar